Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
TCRR - TCR2 Therapeutics Inc.
Market Cap 58.11M P/E - EPS this Y 29.30% Ern Qtrly Grth -
Income -163.1M Forward P/E -0.60 EPS next Y 11.50% 50D Avg Chg -12.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -5.00%
Dividend N/A Price/Book 0.57 EPS next 5Y - 52W High Chg -62.00%
Recommedations 2.80 Quick Ratio 2.32 Shares Outstanding 39.26M 52W Low Chg 80.00%
Insider Own 1.50% ROA -34.73% Shares Float 26.75M Beta 1.93
Inst Own 54.32% ROE -91.46% Shares Shorted/Prior 360.90K/543.77K Price 1.48
Gross Margin - Profit Margin - Avg. Volume 325,397 Target Price 6.43
Oper. Margin - Earnings Date Aug 7 Volume 3,753,354 Change 0.00%
Healthcare | Biotechnology | United States
About TCR2 Therapeutics Inc.

TCR2 Therapeutics Inc., a clinical-stage cell therapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. Its lead product candidate is gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin-expressing solid tumors, which is in Phase 1/2 clinical trial for the treatment of non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal mesothelioma, and cholangiocarcinoma. It is also developing TC-510, a mesothelin-targeted TRuC-T cell that has completed preclinical trials to treat solid tumors; and TC-520, a fratricide resistant CD70 targeting TRuC-T cell for the treatment of renal cell carcinoma and acute myeloid leukemia. The company was formerly known as TCR2, Inc. and changed its name to TCR2 Therapeutics Inc. in November 2016. TCR2 Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

TCRR Chatroom

User Image dhovekamp42 Posted - 7 months ago

@Shockjumper @GinoGino @BiotechJohn NEA still holding well over 5% of the combined $ADAP $TCRR company -- $11 was the last price paid

User Image TrendyChart Posted - 1 year ago

Upcoming Earnings Report: $TCRR TCR2 Therapeutics will be reporting on 11/17/2023 at 6:00AM | What's your inclination regarding earnings for this stock?

User Image TrendyChart Posted - 1 year ago

Upcoming Earnings Report: $TCRR TCR2 Therapeutics will be reporting on 11/17/2023 at 6:00AM | Are you leaning towards a positive or negative earnings stance?

User Image TrendyChart Posted - 10/30/23

Upcoming Earnings Report: $TCRR TCR2 Therapeutics will be reporting on 11/10/2023 at 6:00AM | Are you in favor of positive or negative earnings surprises?

User Image TrendyChart Posted - 10/30/23

Upcoming Earnings Report: $TCRR TCR2 Therapeutics will be reporting on 11/10/2023 at 6:00AM | Are you betting on strong or weak earnings results?

User Image fin_researcher Posted - 10/26/23

$TCRR and $ADAP announced an all-stock merger. $TCRR Therapeutics stockholders will own ~25% of the combined company. $TCRR Investors suspect that pricing terms of the M&A deal with $ADAP are unfair. To join to get compensation: https://11thestate.com/cases/tcrr-adap-mna-investors-case

User Image Ann_Nyc Posted - 1 year ago

$ADAP $TCRR BMS is collab on gavocel trial. ADAP BLA news any day now, target $5 initial.

User Image cctranscripts Posted - 1 year ago

Securities registration termination [Section 12(g)] https://www.conferencecalltranscripts.org/summary/?id=12273207 $TCRR

User Image stockilluminati Posted - 1 year ago

$TCRR https://www.stockilluminati.com/tcrr/filings.php - TCR2 Therapeutics Inc. - Common Stock files form 15-12G today, check out the details.

User Image Quantisnow Posted - 1 year ago

$TCRR 📜 SEC Form 15-12G filed by TCR2 Therapeutics Inc. https://quantisnow.com/i/4627968?utm_source=stocktwits 45 seconds delayed.

User Image shortablestocks Posted - 1 year ago

Zero shares available to short currently in $TCRR. https://shortablestocks.com/?TCRR

User Image Quantisnow Posted - 1 year ago

$TCRR Several insights in the last few minutes: 1. 📜 SEC Form EFFECT filed by TCR2 Therapeutics Inc. https://quantisnow.com/i/4605586?utm_source=stocktwits 2. 📜 SEC Form EFFECT filed by TCR2 Therapeutics Inc. https://quantisnow.com/i/4605615?utm_source=stocktwits #healthcare

User Image Quantisnow Posted - 1 year ago

$TCRR 📜 SEC Form EFFECT filed by TCR2 Therapeutics Inc. https://quantisnow.com/i/4605570?utm_source=stocktwits 45 seconds delayed.

User Image stockilluminati Posted - 1 year ago

$TCRR https://www.stockilluminati.com/tcrr/filings.php - TCR2 Therapeutics Inc. - Common Stock files form EFFECT today, check out the details.

User Image Quantisnow Posted - 1 year ago

$TCRR New live insights: 1. 📜 SEC Form 4 filed by Mpm Bioventures 2014, L.P. https://quantisnow.com/i/4603733?utm_source=stocktwits 2. 📜 SEC Form 4 filed by Mpm Sunstates Fund, L.P. https://quantisnow.com/i/4603746?utm_source=stocktwits 3. 📜 SEC Form 4 filed by Ubs Oncology Impact Fund L.P. https://quantisnow.com/i/4603749?utm_source=stocktwits #healthcare

User Image Quantisnow Posted - 1 year ago

$TCRR 📜 SEC Form 4 filed by Gadicke Ansbert https://quantisnow.com/i/4603715?utm_source=stocktwits 45 seconds delayed.

User Image macroaxis Posted - 1 year ago

$TCRR - Disposition of 24092 shares by Peter Olagunju of Tcr2 Therapeutics subject to Rule 16b 3 - Tcr2 Therapeutics https://www.macroaxis.com/invest/story/TCRR/27574703/Disposition-of-24092-shares-by-Peter-Olagunju-of-Tcr2-Therapeutics-subject-to-Rule-16b-3 #insidertrading #stocks #fintechnews

User Image risenhoover Posted - 1 year ago

$TCRR TCRR / Tcr2 Therapeutics Inc Price Target Updated https://fintel.io/sfo/us/tcrr?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image IanTrader Posted - 1 year ago

$TCRR Is it me or I just got 50+ emails for SEC forms from this company? what's going on?

User Image fla Posted - 1 year ago

$TCRR [15s. delayed] filed form POS AM on June 01, 16:45:31 https://s.flashalert.me/ZgGfpZ

User Image fla Posted - 1 year ago

$TCRR [15s. delayed] filed form POS AM on June 01, 16:44:03 https://s.flashalert.me/dYpdT6

User Image fla Posted - 1 year ago

$TCRR [15s. delayed] filed form POS AM on June 01, 16:43:08 https://s.flashalert.me/b9hQIP

User Image fla Posted - 1 year ago

$TCRR [15s. delayed] filed form S-8 POS on June 01, 16:41:51 https://s.flashalert.me/clm5Wf

User Image fla Posted - 1 year ago

$TCRR [15s. delayed] filed form S-8 POS on June 01, 16:41:17 https://s.flashalert.me/OMd6r

User Image fla Posted - 1 year ago

$TCRR [15s. delayed] filed form S-8 POS on June 01, 16:40:37 https://s.flashalert.me/gPqMNe

User Image fla Posted - 1 year ago

$TCRR [15s. delayed] filed form S-8 POS on June 01, 16:39:35 https://s.flashalert.me/akZ2O7

User Image fla Posted - 1 year ago

$TCRR [15s. delayed] filed form S-8 POS on June 01, 16:38:22 https://s.flashalert.me/TMyfj

User Image risenhoover Posted - 1 year ago

$TCRR / Tcr2 Therapeutics files form S-8 POS https://fintel.io/sf/us/tcrr?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image fla Posted - 1 year ago

$TCRR [15s. delayed] filed SEC form 4: Director Allen Andrew R: Transacted Derivative Securities between 2023-06-01 and 2023-06-01. https://s.flashalert.me/qeG58j

User Image cctranscripts Posted - 1 year ago

Current report, items 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, and 9.01 https://www.conferencecalltranscripts.org/summary/?id=12240303 $TCRR

Analyst Ratings
Mizuho Neutral Mar 24, 23
EF Hutton Hold Mar 23, 23
Jefferies Underperform Mar 9, 23
Truist Securities Hold Mar 8, 23
HC Wainwright & Co. Neutral Mar 7, 23
Piper Sandler Overweight Jan 6, 23
EF Hutton Hold Jan 5, 23
HC Wainwright & Co. Buy Nov 21, 22
SVB Leerink Market Perform Nov 8, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
TANG KEVIN C 10% Owner 10% Owner May 25 Buy 1.72 50,000 86,000 4,394,800 05/30/23
TANG KEVIN C 10% Owner 10% Owner May 11 Buy 1.95 44,948 87,649 4,344,800 05/15/23
TANG KEVIN C 10% Owner 10% Owner May 08 Buy 1.95 83,988 163,777 4,299,852 05/10/23
TANG KEVIN C 10% Owner 10% Owner May 03 Buy 1.89 289,577 547,301 4,215,864 05/05/23
Cardama Alfonso Quintas Chief Medical Office.. Chief Medical Officer Dec 09 Sell 1.1 13,799 15,179 109,459 12/13/22
Olagunju Peter Chief Technical Offi.. Chief Technical Officer Dec 09 Sell 1.1 4,830 5,313 24,092 12/13/22
Justice Angela Chief People Officer Chief People Officer Dec 09 Sell 1.1 8,620 9,482 48,745 12/13/22
Menzel Garry E President and CEO President and CEO Dec 09 Sell 1.1 31,938 35,132 138,871 12/13/22
Cardama Alfonso Quintas Chief Medical Office.. Chief Medical Officer Dec 05 Sell 1.35 7,464 10,076 131,200 12/07/22
Olagunju Peter Chief Technical Offi.. Chief Technical Officer Dec 05 Sell 1.35 2,618 3,534 31,710 12/07/22
Menzel Garry E President and CEO President and CEO Dec 05 Sell 1.36 23,416 31,846 189,234 12/07/22
Justice Angela Chief People Officer Chief People Officer Dec 05 Sell 1.35 4,663 6,295 62,333 12/07/22
Cardama Alfonso Quintas Chief Medical Office.. Chief Medical Officer Dec 01 Sell 1.39 3,636 5,054 138,664 12/05/22
Olagunju Peter Chief Technical Offi.. Chief Technical Officer Dec 01 Sell 1.39 1,273 1,769 34,328 12/05/22
Menzel Garry E President & CEO President & CEO Dec 01 Sell 1.39 8,408 11,687 212,650 12/05/22
Justice Angela Chief People Officer Chief People Officer Dec 01 Sell 1.39 2,273 3,159 66,996 12/05/22
Hofmeister Robert Chief Scientific Off.. Chief Scientific Officer Nov 13 Option 0.74 20,000 14,800 48,852 11/13/20
Hofmeister Robert Chief Scientific Off.. Chief Scientific Officer Nov 13 Sell 25.1 20,000 502,000 38,850 11/13/20